Marijke B. Coomans

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative.

Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative.

Journal: Neuro-oncology

Published: April 28, 2025

Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period.

Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period.

Journal: Neuro-oncology

Published: April 11, 2022

Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling.

Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling.

Journal: Neuro-oncology advances

Published: January 07, 2021

Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients.

Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients.

Journal: Neuro-oncology practice

Published: December 11, 2020

Research Objectives, Statistical Analyses and Interpretation of Health-Related Quality of Life Data in Glioma Research: A Systematic Review.

Research Objectives, Statistical Analyses and Interpretation of Health-Related Quality of Life Data in Glioma Research: A Systematic Review.

Journal: Cancers

Published: October 20, 2020

Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up.

Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 30, 2020

Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?

Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?

Journal: Neuro-oncology

Published: November 05, 2019

Treatment of cognitive deficits in brain tumour patients: current status and future directions.

Treatment of cognitive deficits in brain tumour patients: current status and future directions.

Journal: Current opinion in oncology

Published: September 05, 2019

The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials.

The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 10, 2019

Fatigue in patients with low grade glioma: systematic evaluation of assessment and prevalence.

Fatigue in patients with low grade glioma: systematic evaluation of assessment and prevalence.

Journal: Journal of neuro-oncology

Published: January 25, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026